Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Registry of Older South Australians (ROSA): framework and plan.

Inacio MC, Bray SCE, Whitehead C, Corlis M, Visvanathan R, Evans K, Griffith EC, Wesselingh SL.

BMJ Open. 2019 Jun 19;9(6):e026319. doi: 10.1136/bmjopen-2018-026319.

2.

Do we really understand how faecal microbiota transplantation works? Authors' reply.

Papanicolas LE, Wesselingh SL, Rogers GB.

EBioMedicine. 2019 Apr;42:40. doi: 10.1016/j.ebiom.2019.03.030. Epub 2019 Mar 19. No abstract available.

3.

Case report: Identification of intra-laboratory blood culture contamination with Staphylococcus aureus by whole genome sequencing.

Ashokan A, Papanicolas LE, Leong LEX, Theodossi M, Daniel S, Wesselingh SL, Rogers GB, Gordon DL.

Diagn Microbiol Infect Dis. 2019 Aug;94(4):331-333. doi: 10.1016/j.diagmicrobio.2019.02.016. Epub 2019 Feb 23.

PMID:
30885397
4.

Inclusivity and equity in human microbiome research.

Rogers GB, Ward J, Brown A, Wesselingh SL.

Lancet. 2019 Feb 23;393(10173):728-729. doi: 10.1016/S0140-6736(18)33204-5. No abstract available.

PMID:
30799003
5.

Bacterial viability in faecal transplants: Which bacteria survive?

Papanicolas LE, Choo JM, Wang Y, Leong LEX, Costello SP, Gordon DL, Wesselingh SL, Rogers GB.

EBioMedicine. 2019 Mar;41:509-516. doi: 10.1016/j.ebiom.2019.02.023. Epub 2019 Feb 19.

6.

Optimisation of a propidium monoazide based method to determine the viability of microbes in faecal slurries for transplantation.

Papanicolas LE, Wang Y, Choo JM, Gordon DL, Wesselingh SL, Rogers GB.

J Microbiol Methods. 2019 Jan;156:40-45. doi: 10.1016/j.mimet.2018.12.001. Epub 2018 Dec 4.

PMID:
30529117
7.

Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gut.

Wang Y, Leong LEX, Keating RL, Kanno T, Abell GCJ, Mobegi FM, Choo JM, Wesselingh SL, Mason AJ, Burr LD, Rogers GB.

Gut Microbes. 2019;10(3):367-381. doi: 10.1080/19490976.2018.1534512. Epub 2018 Oct 25.

8.

Burkholderia lata Infections from Intrinsically Contaminated Chlorhexidine Mouthwash, Australia, 2016.

Leong LEX, Lagana D, Carter GP, Wang Q, Smith K, Stinear TP, Shaw D, Sintchenko V, Wesselingh SL, Bastian I, Rogers GB.

Emerg Infect Dis. 2018 Nov;24(11):2109-2111. doi: 10.3201/eid2411.171929.

9.

Antibiotic stewardship in aged care facilities.

Rogers GB, Papanicolas LE, Wesselingh SL.

Lancet Infect Dis. 2018 Oct;18(10):1061-1063. doi: 10.1016/S1473-3099(18)30548-6. No abstract available.

PMID:
30303096
10.

Protocol for an HIV Pre-exposure Prophylaxis (PrEP) Population Level Intervention Study in Victoria Australia: The PrEPX Study.

Ryan KE, Mak A, Stoove M, Price B, Fairley CK, Ruth S, Lal L, Asselin J, El-Hayek C, Nguyen L, Batrouney C, Wilson D, Lockwood J, Murphy D, Cornelisse VJ, Roth N, Willcox J, Chang CC, Armishaw J, Tee BK, Penn M, Forgan-Smith G, Williams C, Montgomery J, Byron K, Coelho A, Allen B, Wiggins J, Kelsall J, Vujovic O, West M, Pierce AB, Gallant D, Bell C, de Wit JBF, Hoy JF, Wesselingh SL, Grant RM, Wright EJ.

Front Public Health. 2018 May 29;6:151. doi: 10.3389/fpubh.2018.00151. eCollection 2018.

11.

Early-Life Antibiotic-Driven Dysbiosis Leads to Dysregulated Vaccine Immune Responses in Mice.

Lynn MA, Tumes DJ, Choo JM, Sribnaia A, Blake SJ, Leong LEX, Young GP, Marshall HS, Wesselingh SL, Rogers GB, Lynn DJ.

Cell Host Microbe. 2018 May 9;23(5):653-660.e5. doi: 10.1016/j.chom.2018.04.009.

12.

Impact of Long-Term Erythromycin Therapy on the Oropharyngeal Microbiome and Resistance Gene Reservoir in Non-Cystic Fibrosis Bronchiectasis.

Choo JM, Abell GCJ, Thomson R, Morgan L, Waterer G, Gordon DL, Taylor SL, Leong LEX, Wesselingh SL, Burr LD, Rogers GB.

mSphere. 2018 Apr 18;3(2). pii: e00103-18. doi: 10.1128/mSphere.00103-18. Print 2018 Apr 25.

13.

Not Just Antibiotics: Is Cancer Chemotherapy Driving Antimicrobial Resistance?

Papanicolas LE, Gordon DL, Wesselingh SL, Rogers GB.

Trends Microbiol. 2018 May;26(5):393-400. doi: 10.1016/j.tim.2017.10.009. Epub 2017 Nov 13. Review.

PMID:
29146383
14.

Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition.

Wong ML, Inserra A, Lewis MD, Mastronardi CA, Leong L, Choo J, Kentish S, Xie P, Morrison M, Wesselingh SL, Rogers GB, Licinio J.

Mol Psychiatry. 2016 Jun;21(6):797-805. doi: 10.1038/mp.2016.46. Epub 2016 Apr 19.

15.

Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells.

Gray LR, On H, Roberts E, Lu HK, Moso MA, Raison JA, Papaioannou C, Cheng WJ, Ellett AM, Jacobson JC, Purcell DF, Wesselingh SL, Gorry PR, Lewin SR, Churchill MJ.

J Neurovirol. 2016 Aug;22(4):455-63. doi: 10.1007/s13365-015-0413-4. Epub 2016 Jan 4.

PMID:
26727904
16.

CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies.

Gray LR, Cowley D, Welsh C, Lu HK, Brew BJ, Lewin SR, Wesselingh SL, Gorry PR, Churchill MJ.

Mol Psychiatry. 2016 Apr;21(4):574-84. doi: 10.1038/mp.2015.111. Epub 2015 Aug 25.

17.

Is the central nervous system a reservoir of HIV-1?

Gray LR, Roche M, Flynn JK, Wesselingh SL, Gorry PR, Churchill MJ.

Curr Opin HIV AIDS. 2014 Nov;9(6):552-8. doi: 10.1097/COH.0000000000000108. Review.

18.

HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research.

Churchill MJ, Cowley DJ, Wesselingh SL, Gorry PR, Gray LR.

J Neurovirol. 2015 Jun;21(3):290-300. doi: 10.1007/s13365-014-0271-5. Epub 2014 Jul 25. Review.

19.

HIV-1 entry and trans-infection of astrocytes involves CD81 vesicles.

Gray LR, Turville SG, Hitchen TL, Cheng WJ, Ellett AM, Salimi H, Roche MJ, Wesselingh SL, Gorry PR, Churchill MJ.

PLoS One. 2014 Feb 28;9(2):e90620. doi: 10.1371/journal.pone.0090620. eCollection 2014.

20.

The NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytes.

Gray LR, Tachedjian G, Ellett AM, Roche MJ, Cheng WJ, Guillemin GJ, Brew BJ, Turville SG, Wesselingh SL, Gorry PR, Churchill MJ.

PLoS One. 2013 Apr 16;8(4):e62196. doi: 10.1371/journal.pone.0062196. Print 2013.

21.

Macrophage-tropic HIV-1 variants from brain demonstrate alterations in the way gp120 engages both CD4 and CCR5.

Salimi H, Roche M, Webb N, Gray LR, Chikere K, Sterjovski J, Ellett A, Wesselingh SL, Ramsland PA, Lee B, Churchill MJ, Gorry PR.

J Leukoc Biol. 2013 Jan;93(1):113-26. doi: 10.1189/jlb.0612308. Epub 2012 Oct 17.

22.

Reduced basal transcriptional activity of central nervous system-derived HIV type 1 long terminal repeats.

Gray LR, Cowley D, Crespan E, Welsh C, Mackenzie C, Wesselingh SL, Gorry PR, Churchill MJ.

AIDS Res Hum Retroviruses. 2013 Feb;29(2):365-70. doi: 10.1089/AID.2012.0138. Epub 2012 Sep 25.

23.

Structural elements of primary CCR5-using HIV-1 gp120 proteins influencing sensitivity and resistance to the broadly neutralizing monoclonal antibody b12.

Sterjovski J, Churchill MJ, Ellett A, Wesselingh SL, Ramsland PA, Gorry PR.

Virology. 2012 Oct 25;432(2):394-404. doi: 10.1016/j.virol.2012.06.024. Epub 2012 Jul 19.

24.

Academic health science centres in Australia: let's get competitive.

Fisk NM, Wesselingh SL, Beilby JJ, Glasgow NJ, Puddey IB, Robinson BG, Angus JA, Smith PJ.

Med J Aust. 2011 Jan 17;194(2):59-60. No abstract available.

PMID:
21241215
25.

CD4-binding site alterations in CCR5-using HIV-1 envelopes influencing gp120-CD4 interactions and fusogenicity.

Sterjovski J, Churchill MJ, Roche M, Ellett A, Farrugia W, Wesselingh SL, Cunningham AL, Ramsland PA, Gorry PR.

Virology. 2011 Feb 20;410(2):418-28. doi: 10.1016/j.virol.2010.12.010. Epub 2011 Jan 8.

26.

CD4 and MHC class 1 down-modulation activities of nef alleles from brain- and lymphoid tissue-derived primary HIV-1 isolates.

Gray LR, Gabuzda D, Cowley D, Ellett A, Chiavaroli L, Wesselingh SL, Churchill MJ, Gorry PR.

J Neurovirol. 2011 Feb;17(1):82-91. doi: 10.1007/s13365-010-0001-6. Epub 2010 Nov 30.

27.

Genetic and functional heterogeneity of CNS-derived tat alleles from patients with HIV-associated dementia.

Cowley D, Gray LR, Wesselingh SL, Gorry PR, Churchill MJ.

J Neurovirol. 2011 Feb;17(1):70-81. doi: 10.1007/s13365-010-0002-5. Epub 2010 Nov 30.

PMID:
21165788
28.

Mitochondrial dysfunction in CD4+ lymphocytes from stavudine-treated HIV patients.

Einsiedel L, Cherry CL, Sheeran FL, Friedhuber A, Wesselingh SL, Pepe S.

Mitochondrion. 2010 Aug;10(5):534-9. doi: 10.1016/j.mito.2010.05.010. Epub 2010 May 31.

PMID:
20685321
29.

An altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopes.

Sterjovski J, Roche M, Churchill MJ, Ellett A, Farrugia W, Gray LR, Cowley D, Poumbourios P, Lee B, Wesselingh SL, Cunningham AL, Ramsland PA, Gorry PR.

Virology. 2010 Sep 1;404(2):269-78. doi: 10.1016/j.virol.2010.05.006. Epub 2010 Jun 8.

30.

Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIV.

Cherry CL, Affandi JS, Brew BJ, Creighton J, Djauzi S, Hooker DJ, Imran D, Kamarulzaman A, Kamerman P, McArthur JC, Moore RD, Price P, Smyth K, Tan IL, Vanar S, Wadley A, Wesselingh SL, Yunihastuti E.

Neurology. 2010 May 11;74(19):1538-42. doi: 10.1212/WNL.0b013e3181dd436d.

31.

Ubisol-Aqua: coenzyme Q10 prevents antiretroviral toxic neuropathy in an in vitro model.

Cherry CL, Mobarok M, Wesselingh SL, Fain R, Weinstock S, Tachedjian G, Srivastava S, Tyssen DP, Glass JD, Hooker DJ.

Curr HIV Res. 2010 Apr;8(3):232-9.

PMID:
20158454
32.

Production and characterization of an orally immunogenic Plasmodium antigen in plants using a virus-based expression system.

Webster DE, Wang L, Mulcair M, Ma C, Santi L, Mason HS, Wesselingh SL, Coppel RL.

Plant Biotechnol J. 2009 Dec;7(9):846-55. doi: 10.1111/j.1467-7652.2009.00447.x. Epub 2009 Sep 28.

33.

Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia.

Churchill MJ, Wesselingh SL, Cowley D, Pardo CA, McArthur JC, Brew BJ, Gorry PR.

Ann Neurol. 2009 Aug;66(2):253-8. doi: 10.1002/ana.21697.

PMID:
19743454
34.

The widening gap between clinical, teaching and research work.

Joyce CM, Piterman L, Wesselingh SL.

Med J Aust. 2009 Aug 3;191(3):169-72.

PMID:
19645649
35.

Cell-specific temporal infection of the brain in a simian immunodeficiency virus model of human immunodeficiency virus encephalitis.

Thompson KA, Varrone JJ, Jankovic-Karasoulos T, Wesselingh SL, McLean CA.

J Neurovirol. 2009 Jul;15(4):300-11. doi: 10.1080/13550280903030125.

PMID:
19593698
36.

Bacterial antigen expression is an important component in inducing an immune response to orally administered Salmonella-delivered DNA vaccines.

Gahan ME, Webster DE, Wesselingh SL, Strugnell RA, Yang J.

PLoS One. 2009 Jun 26;4(6):e6062. doi: 10.1371/journal.pone.0006062.

37.

Measuring and monitoring apoptosis and drug toxicity in HIV patients by ligation-mediated polymerase chain reaction.

Hooker DJ, Gorry PR, Ellett AM, Wesselingh SL, Cherry CL.

J Cell Mol Med. 2009 May;13(5):948-58. doi: 10.1111/j.1582-4934.2008.00612.x. Epub 2008 Dec 16.

38.

Impact of prior immunological exposure on vaccine delivery by Salmonella enterica serovar Typhimurium.

Gahan ME, Webster DE, Wijburg OL, Wesselingh SL, Strugnell RA.

Vaccine. 2008 Nov 18;26(49):6212-20. doi: 10.1016/j.vaccine.2008.09.060. Epub 2008 Oct 11.

PMID:
18852007
39.

Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections.

Clements A, Jenney AW, Farn JL, Brown LE, Deliyannis G, Hartland EL, Pearse MJ, Maloney MB, Wesselingh SL, Wijburg OL, Strugnell RA.

Vaccine. 2008 Oct 16;26(44):5649-53. doi: 10.1016/j.vaccine.2008.07.100. Epub 2008 Aug 24.

PMID:
18725260
40.

A report on the effect of commencing enfuvirtide on peripheral neuropathy.

Cherry CL, Duncan AJ, Mackie KF, Wesselingh SL, Brew BJ.

AIDS Res Hum Retroviruses. 2008 Aug;24(8):1027-30. doi: 10.1089/aid.2007.0300.

PMID:
18724802
41.

Pathogenesis and diagnosis of viral infections of the nervous system.

Wright EJ, Brew BJ, Wesselingh SL.

Neurol Clin. 2008 Aug;26(3):617-33, vii. doi: 10.1016/j.ncl.2008.03.006.

PMID:
18657718
42.

Response to Birbeck et al.

Wright E, Brew BJ, Lal L, Ali ST, Arayawichanont A, Imran D, Kamarulzaman A, Kongsaengdao S, Kruy L, Merati TP, Samintharapanya K, Sarim C, Tau G, Thangsing C, Vin-Samnang C, Wesselingh SL.

Epilepsia. 2008 Mar;49(3):541-3. doi: 10.1111/j.1528-1167.2007.01529_5.x. No abstract available.

43.

Cytokine genotype suggests a role for inflammation in nucleoside analog-associated sensory neuropathy (NRTI-SN) and predicts an individual's NRTI-SN risk.

Cherry CL, Rosenow A, Affandi JS, McArthur JC, Wesselingh SL, Price P.

AIDS Res Hum Retroviruses. 2008 Feb;24(2):117-23. doi: 10.1089/aid.2007.0168.

PMID:
18240960
44.

Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS.

Sterjovski J, Churchill MJ, Ellett A, Gray LR, Roche MJ, Dunfee RL, Purcell DF, Saksena N, Wang B, Sonza S, Wesselingh SL, Karlsson I, Fenyo EM, Gabuzda D, Cunningham AL, Gorry PR.

Retrovirology. 2007 Dec 12;4:89.

45.

Replication-dependent pathogenicity of attenuated nef-deleted HIV-1 in vivo.

Gorry PR, Churchill M, Learmont J, Cherry C, Dyer WB, Wesselingh SL, Sullivan JS.

J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):390-4.

PMID:
17993857
46.

Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.

Gorry PR, McPhee DA, Verity E, Dyer WB, Wesselingh SL, Learmont J, Sullivan JS, Roche M, Zaunders JJ, Gabuzda D, Crowe SM, Mills J, Lewin SR, Brew BJ, Cunningham AL, Churchill MJ.

Retrovirology. 2007 Sep 23;4:66.

47.

Immunogenicity of Plasmodium yoelii merozoite surface protein 4/5 produced in transgenic plants.

Wang L, Webster DE, Campbell AE, Dry IB, Wesselingh SL, Coppel RL.

Int J Parasitol. 2008 Jan;38(1):103-10. Epub 2007 Jul 5.

PMID:
17681344
48.

Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993-2006.

Smyth K, Affandi JS, McArthur JC, Bowtell-Harris C, Mijch AM, Watson K, Costello K, Woolley IJ, Price P, Wesselingh SL, Cherry CL.

HIV Med. 2007 Sep;8(6):367-73.

49.

Phenotype and envelope gene diversity of nef-deleted HIV-1 isolated from long-term survivors infected from a single source.

Gray L, Churchill MJ, Sterjovski J, Witlox K, Learmont JC, Sullivan JS, Wesselingh SL, Gabuzda D, Cunningham AL, McPhee DA, Gorry PR.

Virol J. 2007 Jul 16;4:75.

50.

A DNA prime, orally delivered protein boost vaccination strategy against viral encephalitis.

Zanin MP, Webster DE, Wesselingh SL.

J Neurovirol. 2007 Jun;13(3):284-9.

PMID:
17613719

Supplemental Content

Loading ...
Support Center